Insulin and proinsulin release during calcium infusion in a patient with islet-cell tumor.
The infusion of calcium results in the release of gastrin, calcitonin, and serotonin from certain nonbeta islet cell tumors of the pancreas, medullary carcinomas of the thyroid, and carcinoid tumors, respectively. In this study, intravenous infusion of either calcium chloride or calcium aluconate in a patient with an islet-cell carcinoma resulted in a simultaneous rise in plasma immunoreactive insulin and proinsulin, and concurrent hypoglycemia. After resection of the tumor, calcium infusion caused no change in these parameters. Similarly, calcium infusion caused no change in plasma insulin or glucose in normal volunteers. The response of this tumor suggests that calcium infusion may be a useful provocative test to detect insulin-secreting neoplasia. A derangement of the stimulus-secretion coupling mechanism for insulin in the tumor cells may be responsible for their abnormal sensitivity to calcium ion.
D007516:Adenoma, Islet Cell / Q000175:diagnosis / Q000503:physiopathology*; D001786:Blood Glucose / Q000378:metabolism; D002118:Calcium / Q000097:blood; D002122:Calcium Chloride; D002277:Carcinoma / Q000175:diagnosis / Q000503:physiopathology; D005260:Female; D005942:Gluconates; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008875:Middle Aged; D011384:Proinsulin / Q000378:metabolism*
D001786:Blood Glucose; D005942:Gluconates; D007328:Insulin; D011384:Proinsulin; D002122:Calcium Chloride; D002118:Calcium